These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7904009)

  • 21. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated?
    Lopaschuk GD
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S8-11. PubMed ID: 11286307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose, insulin and myocardial ischaemia.
    Devos P; Chioléro R; Van den Berghe G; Preiser JC
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):131-9. PubMed ID: 16477178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of metabolically active drugs in the management of ischemic heart disease.
    Schofield RS; Hill JA
    Am J Cardiovasc Drugs; 2001; 1(1):23-35. PubMed ID: 14728049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease.
    Curtis MJ; Pugsley MK; Walker MJ
    Cardiovasc Res; 1993 May; 27(5):703-19. PubMed ID: 8348568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelin and ischaemic arrhythmias-antiarrhythmic or arrhythmogenic?
    Sharif I; Kane KA; Wainwright CL
    Cardiovasc Res; 1998 Sep; 39(3):625-32. PubMed ID: 9861305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myocardial metabolism and metabolic drugs].
    Olesova VM; Markatiuk OIu; Iurova IuIu; Obrezan AG
    Kardiologiia; 2013; 53(1):66-71. PubMed ID: 23548353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats.
    McLennan PL; Dallimore JA
    J Nutr; 1995 Apr; 125(4):1003-9. PubMed ID: 7722678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the roles of long-chain acyl carnitine accumulation and impaired glucose utilization in ischaemic contracture development and tissue damage in the guinea-pig heart.
    Clarke B; Wyatt KM; May GR; McCormack JG
    J Mol Cell Cardiol; 1996 Jan; 28(1):171-81. PubMed ID: 8745225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischaemic preconditioning.
    Papp R; Gönczi M; Kovács M; Seprényi G; Végh A
    Cardiovasc Res; 2007 Jun; 74(3):396-405. PubMed ID: 17362896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes of myocardial enzymes related to glycolysis and fatty acid metabolism in chronic myocardial ischemia: experiment with pigs].
    Gong J; Wang HY; Pu JL; Zheng YL; Shen R; Yang MF; He ZX
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(31):2209-13. PubMed ID: 19080674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action.
    Nair SS; Leitch JW; Falconer J; Garg ML
    J Nutr; 1997 Mar; 127(3):383-93. PubMed ID: 9082021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-arrhythmic protection by ischaemic preconditioning in isolated rat hearts is not due to depletion of endogenous catecholamines.
    Lawson CS; Hearse DJ
    Cardiovasc Res; 1996 Apr; 31(4):655-62. PubMed ID: 8689659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.
    Lopaschuk GD; Wambolt RB; Barr RL
    J Pharmacol Exp Ther; 1993 Jan; 264(1):135-44. PubMed ID: 8380856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic imaging in myocardial ischemia and heart failure.
    Knuuti J; Tuunanen H
    Q J Nucl Med Mol Imaging; 2010 Apr; 54(2):168-76. PubMed ID: 20588213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats.
    McLennan PL
    Am J Clin Nutr; 1993 Feb; 57(2):207-12. PubMed ID: 8424390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
    Ussher JR; Lopaschuk GD
    Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myocardial tolerance to arrhythmogenic exposure and pharmacological activation of K(ATP)-channels in rats].
    Maslov LN; Krylatov AV; Lishmanov AIu; Solenkova NV; Bogomaz SA
    Eksp Klin Farmakol; 2001; 64(2):41-4. PubMed ID: 11548447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulation.
    Fraser H; Lopaschuk GD; Clanachan AS
    Br J Pharmacol; 1999 Sep; 128(1):197-205. PubMed ID: 10498852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Activation of opioid receptors changes heart resistance to an arrhythmogenic action of ischemia and reperfusion].
    Lishmanov IuB; Maslov LN; Gross GG
    Patol Fiziol Eksp Ter; 2007; (2):21-6. PubMed ID: 17902219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.